ID

12471

Descrizione

The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01294462

collegamento

https://clinicaltrials.gov/ct2/show/NCT01294462

Keywords

versioni (2)
  1. 28/07/15 28/07/15 -
  2. 21/11/15 21/11/15 -
Caricato su

21 novembre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Ticagrelor Versus Clopidogrel Acute Coronary Syndrome NCT01294462

Inglese

Eligibility criteria

1 moduli  
  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Descrizione

Inclusion Criteria

Provision of signed informed consent
Descrizione

Provision of signed informed consent

Tipo di dati

boolean

Alias
UMLS CUI-1
C0021430
Index event of ST segment elevation ACS
Descrizione

Index event of non-ST or ST segment elevation ACS

Tipo di dati

boolean

Alias
UMLS CUI-1
C1536220
Index event of non-ST segment elevation ACS
Descrizione

Index event of non-ST segment elevation ACS

Tipo di dati

boolean

Alias
UMLS CUI-1
C3537184
Exclusion criteria
Descrizione

Exclusion criteria

Index event is an acute complication of percutaneous coronary intervention
Descrizione

Index event is an acute complication of percutaneous coronary intervention

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C1532338
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
Descrizione

Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment

Tipo di dati

boolean

Alias
UMLS CUI-1
C1532338
Oral anticoagulation therapy that cannot be stopped
Descrizione

Oral anticoagulation therapy that cannot be stopped

Tipo di dati

boolean

Alias
UMLS CUI-1
C0003281
The conditions associated with increased risk of bradycardiac events
Descrizione

The conditions associated with increased risk of bradycardiac events

Tipo di dati

boolean

Alias
UMLS CUI-1
C0428977
Ritorna all'inizio della pagina

Similar models

Eligibility criteria

1 moduli
  1. StudyEvent: ODM
    1. Eligibility criteria
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion Criteria
Informed consent
Item
Provision of signed informed consent
boolean
C0021430 (UMLS CUI-1)
STEMI
Item
Index event of ST segment elevation ACS
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
Index event of non-ST segment elevation ACS
boolean
C3537184 (UMLS CUI-1)
Item Group
Exclusion criteria
PCI complication
Item
Index event is an acute complication of percutaneous coronary intervention
boolean
C0009566 (UMLS CUI [1,1])
C1532338 (UMLS CUI [1,2])
PCI
Item
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
boolean
C1532338 (UMLS CUI-1)
anticoagulation therapy
Item
Oral anticoagulation therapy that cannot be stopped
boolean
C0003281 (UMLS CUI-1)
Bradycardia
Item
The conditions associated with increased risk of bradycardiac events
boolean
C0428977 (UMLS CUI-1)
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial